OUP Management as of March 31, 2022
Portfolio Holdings for OUP Management
OUP Management holds 16 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ionQ Common Stock (IONQ) | 22.5 | $30M | 2.3M | 12.76 | |
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 20.1 | $26M | 2.9M | 8.97 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 15.7 | $21M | 989k | 20.82 | |
| Aerovate Therapeutics Common Stock (AVTE) | 8.4 | $11M | 604k | 18.33 | |
| DICE Therapeutics Common Stock | 7.8 | $10M | 537k | 19.13 | |
| Cyteir Therapeutics Common Stock | 7.1 | $9.3M | 2.5M | 3.77 | |
| Evolv Technologies Holdings Common Stock (EVLV) | 3.7 | $4.8M | 1.8M | 2.65 | |
| eFFECTOR Therapeutics Common Stock | 3.1 | $4.1M | 1.0M | 4.01 | |
| Precision BioSciences Common Stock | 2.6 | $3.5M | 1.1M | 3.08 | |
| Landos Biopharma Common Stock | 2.1 | $2.7M | 1.8M | 1.48 | |
| Vor Biopharma Common Stock (VOR) | 1.7 | $2.3M | 375k | 6.04 | |
| Spero Therapeutics Common Stock (SPRO) | 1.6 | $2.2M | 249k | 8.70 | |
| Graphite Bio Common Stock | 1.6 | $2.1M | 406k | 5.10 | |
| Sera Prognostics Common Stock (SERA) | 1.0 | $1.3M | 338k | 3.79 | |
| Selecta Biosciences Common Stock (RNAC) | 0.8 | $1.1M | 863k | 1.23 | |
| Homology Medicines Common Stock | 0.1 | $195k | 64k | 3.05 |
